InvestSMART

Company announcements

leave blank for all companies
leave blank for all announcements
announcements

~ We have limited the announcement data displayed on our website to the past 12 months to ensure its accuracy and usefulness.
Search Results
Company Sector Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
Acrux Limited (ACR)
ORDINARY FULLY PAID
Health Care $7 Orion manufacturing facility, Finland 24 Nov 2011 4:14PM $2.830 $0.014 fallen by 99.51%
Acrux Limited (ACR)
ORDINARY FULLY PAID
Health Care $7 2026 patent for Axiron granted by Australian patent office 3 Nov 2011 11:43AM $3.340 $0.014 fallen by 99.58%
Acrux Limited (ACR)
ORDINARY FULLY PAID
Health Care $7 Marketing authorisation for Recuvyra granted in Europe 13 Oct 2011 10:16AM $3.580 $0.014 fallen by 99.61%
Acrux Limited (ACR)
ORDINARY FULLY PAID
Health Care $7 Appendix 4E and Financial Report for the year ended 30 June 23 Aug 2011 8:30AM $3.100 $0.014 fallen by 99.55%
Acrux Limited (ACR)
ORDINARY FULLY PAID
Health Care $7 Appendix 4C - Quarterly Cash Flow Report 29 Jul 2011 5:40PM $3.780 $0.014 fallen by 99.63%
Acrux Limited (ACR)
ORDINARY FULLY PAID
Health Care $7 Eli Lilly provides feedback on initial uptake of Axiron 1 Jul 2011 12:53PM $3.440 $0.014 fallen by 99.59%
Acrux Limited (ACR)
ORDINARY FULLY PAID
Health Care $7 Acrux receives marketing approval for Ellavie in Sweden 27 May 2011 9:35AM $3.620 $0.014 fallen by 99.61%
Acrux Limited (ACR)
ORDINARY FULLY PAID
Health Care $7 Positive European opinion for first animal health product 10 May 2011 12:43PM $3.500 $0.014 fallen by 99.60%
Acrux Limited (ACR)
ORDINARY FULLY PAID
Health Care $7 Appendix 4C - Quarterly Cash Flow Report 29 Apr 2011 5:24PM $3.500 $0.014 fallen by 99.60%
Acrux Limited (ACR)
ORDINARY FULLY PAID
Health Care $7 Axiron Launched by Eli Lilly in the United States 31 Mar 2011 10:52AM $3.020 $0.014 fallen by 99.54%
Acrux Limited (ACR)
ORDINARY FULLY PAID
Health Care $7 Acrux Declares First Dividend of 60 cents per share 24 Mar 2011 10:35AM $3.570 $0.014 fallen by 99.61%
Acrux Limited (ACR)
ORDINARY FULLY PAID
Health Care $7 Half Year Accounts and Appendix 4D 24 Feb 2011 9:29AM $3.700 $0.014 fallen by 99.62%
Acrux Limited (ACR)
ORDINARY FULLY PAID
Health Care $7 Appendix 4C - Quarterly Cash Flow Report 31 Jan 2011 4:20PM $3.550 $0.014 fallen by 99.61%
Acrux Limited (ACR)
ORDINARY FULLY PAID
Health Care $7 2010 AGM Presentations 30 Nov 2010 2:00PM $3.380 $0.014 fallen by 99.59%
Acrux Limited (ACR)
ORDINARY FULLY PAID
Health Care $7 Market Update 24 Nov 2010 2:10PM $3.360 $0.014 fallen by 99.58%
Acrux Limited (ACR)
ORDINARY FULLY PAID
Health Care $7 FDA Approval for AXIRON 24 Nov 2010 2:10PM $3.360 $0.014 fallen by 99.58%
Acrux Limited (ACR)
ORDINARY FULLY PAID
Health Care $7 Trading Halt 24 Nov 2010 9:28AM $3.360 $0.014 fallen by 99.58%
Acrux Limited (ACR)
ORDINARY FULLY PAID
Health Care $7 Response to ASX Price Query 1 Nov 2010 8:58AM $3.070 $0.014 fallen by 99.54%
Acrux Limited (ACR)
ORDINARY FULLY PAID
Health Care $7 Appendix 4C - Quarterly Cash Flow Report 29 Oct 2010 5:24PM $3.140 $0.014 fallen by 99.55%
Acrux Limited (ACR)
ORDINARY FULLY PAID
Health Care $7 Appendix 4E and 30 June 2010 Financial Report 24 Aug 2010 9:43AM $2.010 $0.014 fallen by 99.30%
Acrux Limited (ACR)
ORDINARY FULLY PAID
Health Care $7 Update on Acrux female health products 10 Aug 2010 10:56AM $1.990 $0.014 fallen by 99.30%
Acrux Limited (ACR)
ORDINARY FULLY PAID
Health Care $7 Appendix 4C - Quarterly Cash Flow Report 30 Jul 2010 12:06PM $1.950 $0.014 fallen by 99.28%
Acrux Limited (ACR)
ORDINARY FULLY PAID
Health Care $7 Settlement Agreement Transferring Luramist Assets to Acrux 11 May 2010 1:48PM $1.900 $0.014 fallen by 99.26%
Acrux Limited (ACR)
ORDINARY FULLY PAID
Health Care $7 Appendix 4C - Quarterly Cash Flow Report 30 Apr 2010 4:45PM $1.910 $0.014 fallen by 99.27%
Acrux Limited (ACR)
ORDINARY FULLY PAID
Health Care $7 New Drug Application for AXIRON accepted for review by FDA 15 Apr 2010 10:05AM $2.290 $0.014 fallen by 99.39%

551 - 575 of 685 results

Page 23 of 28

  • + Company announcements and prices are delayed by at least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.